PT Soho Global Health Tbk(ID:SOHO)
Rp1,130.00-45.00 (-3.83%)
ID:SOHO
PT Soho Global Health Tbk financials statements
Rp1,130.00
At close:-45.00 (-3.83%)
PT Soho Global Health Tbk (SOHO) Ratios
PT Soho Global Health Tbk Ratios
ID:SOHO's free cash flow for Q2 2026 was Rp464.98B. For the 2026 fiscal year, ID:SOHO's free cash flow was decreased by Rp-9.15B and operating cash flow was Rp474.13B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.63 | 1.88 | 1.89 | 2.04 | 2.02 |
| Quick Ratio | 1.17 | 1.24 | 1.26 | 1.44 | 1.34 |
| Cash Ratio | 0.33 | 0.17 | 0.31 | 0.59 | 0.58 |
| Solvency Ratio | 0.19 | 0.20 | 0.19 | 0.21 | 0.34 |
| Operating Cash Flow Ratio | 0.27 | -0.04 | 0.10 | 0.19 | 0.38 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | Rp 1.94T | Rp 2.05T | Rp 1.79T | Rp 1.83T | Rp 1.53T |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.38 | 1.99 | 1.98 | 1.84 | 1.82 |
| Debt Service Coverage Ratio | 198.98 | 77.19 | 90.81 | 97.98 | 123.22 |
| Interest Coverage Ratio | 215.39 | 82.47 | 89.14 | 101.92 | 134.18 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.84 | 1.72 | 1.96 | 2.00 | 23.01 |
| Net Debt to EBITDA | -1.30 | -0.62 | -1.24 | -2.11 | -1.22 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.28% | 15.32% | 15.74% | 18.36% | 22.18% |
| EBIT Margin | 7.16% | 5.86% | 5.71% | 6.31% | 9.84% |
| EBITDA Margin | 7.83% | 6.56% | 6.57% | 7.20% | 10.78% |
| Operating Profit Margin | 6.76% | 5.68% | 5.35% | 6.09% | 9.58% |
| Pretax Profit Margin | 7.16% | 5.85% | 5.65% | 6.25% | 9.77% |
| Net Profit Margin | 5.57% | 4.60% | 4.53% | 4.89% | 7.78% |
| Continuous Operations Profit Margin | 5.57% | 4.60% | 4.53% | 4.90% | 7.79% |
| Net Income Per EBT | 77.78% | 78.68% | 80.13% | 78.29% | 79.60% |
| EBT Per EBIT | 105.96% | 102.94% | 105.64% | 102.70% | 101.92% |
| Return on Assets (ROA) | 9.75% | 8.55% | 7.82% | 7.97% | 13.68% |
| Return on Equity (ROE) | 23.24% | 17.04% | 15.48% | 14.69% | 24.92% |
| Return on Capital Employed (ROCE) | 26.19% | 19.80% | 17.13% | 17.23% | 28.64% |
| Return on Invested Capital (ROIC) | 20.34% | 15.53% | 13.67% | 13.45% | 22.78% |
| Return on Tangible Assets | 9.77% | 8.57% | 7.86% | 8.02% | 13.77% |
| Earnings Yield | 3.45% | 5.74% | 5.85% | 5.18% | 68.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.67 | 4.69 | 4.84 | 5.15 | 6.46 |
| Payables Turnover | 3.42 | 3.85 | 3.62 | 3.70 | 4.28 |
| Inventory Turnover | 5.78 | 5.25 | 4.97 | 5.18 | 4.92 |
| Fixed Asset Turnover | 21.58 | 19.85 | 18.11 | 16.31 | 15.45 |
| Asset Turnover | 1.75 | 1.86 | 1.73 | 1.63 | 1.76 |
| Working Capital Turnover Ratio | 4.94 | 4.82 | 4.17 | 3.98 | 4.29 |
| Cash Conversion Cycle | 34.59 | 52.55 | 48.14 | 42.53 | 45.42 |
| Days of Sales Outstanding | 78.11 | 77.87 | 75.42 | 70.85 | 56.47 |
| Days of Inventory Outstanding | 63.19 | 69.54 | 73.49 | 70.41 | 74.15 |
| Days of Payables Outstanding | 106.71 | 94.86 | 100.77 | 98.73 | 85.19 |
| Operating Cycle | 141.30 | 147.41 | 148.91 | 141.26 | 130.62 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 72.32 | -8.70 | 16.64 | 28.11 | 496.77 |
| Free Cash Flow Per Share | 67.84 | -17.24 | 13.58 | 24.14 | 467.91 |
| Dividend Paid and CapEx Coverage Ratio | 2.57 | -0.42 | 0.48 | 1.78 | 1.08 |
| Capital Expenditure Coverage Ratio | 16.14 | -1.02 | 5.45 | 7.09 | 17.21 |
| Operating Cash Flow Coverage Ratio | 127.14 | -7.43 | 10.58 | 16.97 | 26.11 |
| Operating Cash Flow to Sales Ratio | 0.09 | -0.01 | 0.03 | 0.05 | 0.09 |
| Free Cash Flow Yield | 4.95% | -2.72% | 2.72% | 4.45% | 73.40% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 28.96 | 17.42 | 17.09 | 19.30 | 14.72 |
| Price-to-Sales (P/S) Ratio | 1.61 | 0.80 | 0.77 | 0.94 | 0.11 |
| Price-to-Book (P/B) Ratio | 6.73 | 2.97 | 2.65 | 2.84 | 0.37 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 20.20 | -36.82 | 36.81 | 22.47 | 1.36 |
| Price-to-Operating Cash Flow Ratio | 18.94 | -72.96 | 30.06 | 19.30 | 1.28 |
| Price-to-Earnings Growth (PEG) Ratio | 0.97 | 0.71 | 4.18 | -0.55 | 0.12 |
| Enterprise Value Multiple | 19.29 | 11.59 | 10.53 | 11.01 | -0.16 |
| Enterprise Value | 16.29T | 7.65T | 5.68T | 5.78T | -120.05B |
| EV to EBITDA | 19.29 | 11.59 | 10.53 | 11.01 | -0.16 |
| EV to Sales | 1.51 | 0.76 | 0.69 | 0.79 | -0.02 |
| EV to Free Cash Flow | 18.92 | -34.96 | 32.94 | 18.86 | -0.20 |
| EV to Operating Cash Flow | 17.75 | -69.27 | 26.89 | 16.20 | -0.19 |
| Tangible Book Value Per Share | 202.41 | 212.67 | 187.44 | 189.18 | 1719.62 |
| Shareholders’ Equity Per Share | 203.52 | 213.94 | 189.03 | 191.27 | 1739.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.21 | 0.20 | 0.22 | 0.20 |
| Revenue Per Share | 849.31 | 792.48 | 645.92 | 574.40 | 5575.44 |
| Net Income Per Share | 47.30 | 36.45 | 29.26 | 28.11 | 433.49 |
| Tax Burden | 0.78 | 0.79 | 0.80 | 0.78 | 0.80 |
| Interest Burden | 1.00 | 1.00 | 0.99 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.05 | 0.04 | 0.10 | 0.06 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.53 | -0.24 | 0.57 | 1.00 | 1.15 |
Currency in IDR
